Insights

Growing Market Presence Biogen has demonstrated consistent growth with a 15.1% increase in shares in 2025, driven by successful product launches such as Leqembi and Skyclarys. This indicates increasing market acceptance and offers opportunities to position complementary therapies or diagnostic solutions targeting neurodegenerative conditions.

Strategic Focus on Neurodegeneration The company's notable research and clinical advancements in ALS and neurodegenerative disorders like SOD1-ALS highlight a strong pipeline and expertise in these areas. This creates potential for collaborations or sales of specialized treatment support tools, biomarkers, or patient management systems for neurodegenerative diseases.

Financial Stability with Investment Potential With substantial revenue and a robust funding of $1.5 billion, Biogen is positioned for continued R&D investment and expansion. Engaging with the company on innovative biotech solutions or manufacturing support services could match their growth trajectory and investment plans.

Global Presence and Distribution Biogen’s operations span over 30 countries with distribution partners in more than 50 regions, reflecting a broad international reach. This provides a sales opportunity for global logistics, supply chain solutions, or localized marketing services to strengthen their distribution network.

Technological Innovation Biogen employs advanced tech stacks including Salesforce, MongoDB, and Python, indicating a sophisticated and data-driven workflow. Introducing AI-driven analytics, data security solutions, or automation tools could enhance their R&D efficiency and operational agility.

Biogen Tech Stack

Biogen uses 8 technology products and services including Salesforce, MongoDB, Nasuni, and more. Explore Biogen's tech stack below.

  • Salesforce
    Customer Relationship Management
  • MongoDB
    Database
  • Nasuni
    Document Management Systems
  • TrackWise
    Governance, Risk And Compliance
  • SAML
    Identity And Access Management
  • SailPoint Identity and Access Management
    Identity And Access Management
  • Reddit
    Message Boards
  • Python
    Programming Languages

Media & News

Biogen's Email Address Formats

Biogen uses at least 2 format(s):
Biogen Email FormatsExamplePercentage
First.Last@biogen.comJohn.Doe@biogen.com
85%
First_Last@biogen.comJohn_Doe@biogen.com
13%
F.Last@biogen.comJ.Doe@biogen.com
1%
First.Middle@biogen.comJohn.Michael@biogen.com
1%
First.Last@biogenidec.comJohn.Doe@biogenidec.com
95%
Last@biogenidec.comDoe@biogenidec.com
1%
F.Last@biogenidec.comJ.Doe@biogenidec.com
1%
First_Last@biogenidec.comJohn_Doe@biogenidec.com
1%
FirstMiddle.Last@biogenidec.comJohnMichael.Doe@biogenidec.com
1%
FirstLast@biogenidec.comJohnDoe@biogenidec.com
1%

Frequently Asked Questions

What is Biogen's phone number?

Minus sign iconPlus sign icon
You can contact Biogen's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Biogen's stock symbol?

Minus sign iconPlus sign icon
Biogen is a publicly traded company; the company's stock symbol is BIIB.

What is Biogen's official website and social media links?

Minus sign iconPlus sign icon
Biogen's official website is biogen.com and has social profiles on LinkedInCrunchbase.

How much revenue does Biogen generate?

Minus sign iconPlus sign icon
As of December 2025, Biogen's annual revenue is estimated to be $9.8B.

What is Biogen's SIC code NAICS code?

Minus sign iconPlus sign icon
Biogen's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Biogen have currently?

Minus sign iconPlus sign icon
As of December 2025, Biogen has approximately 7.5K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Cmo Quality Lead: G. S.Chief Information Security Officer: R. K.Chief Security Officer (v.P) Global Security: K. S.. Explore Biogen's employee directory with LeadIQ.

What industry does Biogen belong to?

Minus sign iconPlus sign icon
Biogen operates in the Biotechnology Research industry.

What technology does Biogen use?

Minus sign iconPlus sign icon
Biogen's tech stack includes SalesforceMongoDBNasuniTrackWiseSAMLSailPoint Identity and Access ManagementRedditPython.

What is Biogen's email format?

Minus sign iconPlus sign icon
Biogen's email format typically follows the pattern of First.Last@biogen.com. Find more Biogen email formats with LeadIQ.

How much funding has Biogen raised to date?

Minus sign iconPlus sign icon
As of December 2025, Biogen has raised $1.5B in funding. The last funding round occurred on Aug 28, 2023 for $1.5B.

Biogen

Biotechnology ResearchMassachusetts, United States5001-10000 Employees

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. 

We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.

With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.

For more information, please visit www.biogen.com. Community Guidelines: https://www.biogen.com/community-guidelines.html

Follow us on social media –  LinkedIn, Facebook, X, and YouTube.

Section iconCompany Overview

Phone number
Website
biogen.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BIIB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
5001-10000

Section iconFunding & Financials

  • $1.5B

    Biogen has raised a total of $1.5B of funding over 1 rounds. Their latest funding round was raised on Aug 28, 2023 in the amount of $1.5B.

  • $1B$10B

    Biogen's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1.5B

    Biogen has raised a total of $1.5B of funding over 1 rounds. Their latest funding round was raised on Aug 28, 2023 in the amount of $1.5B.

  • $1B$10B

    Biogen's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.